DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Solaimanzadeh I.
Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19).
Cureus 2020;
12 (03) e7343
We do not assume any responsibility for the contents of the web pages of other providers.